title: Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer.
authors.affiliation: Genetic Medicine, St Mary's Hospital, Oxford Road, Manchester, UK. gareth.evans@cmft.nhs.uk
authors.forename: D G
authors.initials: DG
authors.lastname: Evans
authors.forename: A
authors.initials: A
authors.lastname: Howell
authors.forename: D
authors.initials: D
authors.lastname: Ward
authors.forename: F
authors.initials: F
authors.lastname: Lalloo
authors.forename: J L
authors.initials: JL
authors.lastname: Jones
authors.forename: D M
authors.initials: DM
authors.lastname: Eccles
mesh_terms: D000328:Adult; D019313:BRCA1 Protein / Q000235:genetics*; D024682:BRCA2 Protein / Q000235:genetics*; D001943:Breast Neoplasms / Q000235:genetics*; D005260:Female; D006801:Humans; D009154:Mutation / Q000235:genetics*
chemical_list: D019313:BRCA1 Protein; C492913:BRCA1 protein, human; D024682:BRCA2 Protein; C551750:BRCA2 protein, human